These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34596323)

  • 1. Children living with HIV in Europe: do migrants have worse treatment outcomes?
    Chappell E; Kohns Vasconcelos M; Goodall RL; Galli L; Goetghebuer T; Noguera-Julian A; Rodrigues LC; Scherpbier H; Smit C; Bamford A; Crichton S; Navarro ML; Ramos JT; Warszawski J; Spolou V; Chiappini E; Venturini E; Prata F; Kahlert C; Marczynska M; Marques L; Naver L; Thorne C; Gibb DM; Giaquinto C; Judd A; Collins IJ;
    HIV Med; 2022 Feb; 23(2):186-196. PubMed ID: 34596323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study.
    European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group in EuroCoord
    Clin Infect Dis; 2020 Jan; 70(3):404-415. PubMed ID: 30919882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis.
    ; Shepherd BE; Jenkins CA; Parrish DD; Glass TR; Cescon A; Masabeu A; Chene G; de Wolf F; Crane HM; Jarrin I; Gill J; del Amo J; Abgrall S; Khaykin P; Lehmann C; Ingle SM; May MT; Sterne JA; Sterling TR
    AIDS; 2013 May; 27(8):1321-9. PubMed ID: 23925379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migrant women living with HIV in Europe: are they facing inequalities in the prevention of mother-to-child-transmission of HIV?: The European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord.
    Favarato G; Bailey H; Burns F; Prieto L; Soriano-Arandes A; Thorne C
    Eur J Public Health; 2018 Feb; 28(1):55-60. PubMed ID: 28449111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
    Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
    HIV Med; 2018 Jan; 19(1):42-48. PubMed ID: 28741837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of a cohort of migrants and citizens living with human immunodeficiency virus in Botswana: implications for Joint United Nation Program on HIV and AIDS 90-90-90 targets.
    Marukutira T; Yin D; Cressman L; Kariuki R; Malone B; Spelman T; Mawandia S; Ledikwe JH; Semo BW; Crowe S; Stoove M; Hellard M; Dickinson D
    Medicine (Baltimore); 2019 Jun; 98(23):e15994. PubMed ID: 31169739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.
    Saracino A; Lorenzini P; Lo Caputo S; Girardi E; Castelli F; Bonfanti P; Rusconi S; Caramello P; Abrescia N; Mussini C; Monno L; d'Arminio Monforte A;
    Clin Microbiol Infect; 2016 Mar; 22(3):288.e1-8. PubMed ID: 26551839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaps in the HIV diagnosis and care cascade for migrants in Australia, 2013-2017: A cross-sectional study.
    Marukutira T; Gray RT; Douglass C; El-Hayek C; Moreira C; Asselin J; Donovan B; Vickers T; Spelman T; Crowe S; Guy R; Stoove M; Hellard M
    PLoS Med; 2020 Mar; 17(3):e1003044. PubMed ID: 32155145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated risk of viral rebound on ART in migrants living in France: role of socioeconomic factors.
    Abgrall S; Raho-Moussa M; Seng R; Ghislain M; Matheron S; Pialoux G; Goujard C; Meyer L;
    Antivir Ther; 2019; 24(7):541-552. PubMed ID: 31868654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study.
    Iyun V; Technau KG; Vinikoor M; Yotebieng M; Vreeman R; Abuogi L; Desmonde S; Edmonds A; Amorissani-Folquet M; Davies MA;
    Lancet HIV; 2021 Jun; 8(6):e353-e362. PubMed ID: 33932330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?
    Gatey C; Brun A; Hamet G; Diamantis S; Sellier P; Bouchaud O; Garrait V; Rozenbaum W; Molina JM; Abgrall S;
    HIV Med; 2019 Feb; 20(2):175-181. PubMed ID: 30506853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
    Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
    Lodi S; Phillips A; Logan R; Olson A; Costagliola D; Abgrall S; van Sighem A; Reiss P; Miró JM; Ferrer E; Justice A; Gandhi N; Bucher HC; Furrer H; Moreno S; Monge S; Touloumi G; Pantazis N; Sterne J; Young JG; Meyer L; Seng R; Dabis F; Vandehende MA; Pérez-Hoyos S; Jarrín I; Jose S; Sabin C; Hernán MA;
    Lancet HIV; 2015 Aug; 2(8):e335-43. PubMed ID: 26423376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
    Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
    J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.
    de Monteynard LA; Dray-Spira R; de Truchis P; Grabar S; Launay O; Meynard JL; Khuong-Josses MA; Gilquin J; Rey D; Simon A; Pavie J; Mahamat A; Matheron S; Costagliola D; Abgrall S;
    PLoS One; 2015; 10(3):e0118492. PubMed ID: 25734445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
    ; Babiker A; Castro nee Green H; Compagnucci A; Fiscus S; Giaquinto C; Gibb DM; Harper L; Harrison L; Hughes M; McKinney R; Melvin A; Mofenson L; Saidi Y; Smith ME; Tudor-Williams G; Walker AS
    Lancet Infect Dis; 2011 Apr; 11(4):273-83. PubMed ID: 21288774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to combination antiretroviral therapy: variation by age.
    ; Sabin CA; Smith CJ; d'Arminio Monforte A; Battegay M; Gabiano C; Galli L; Geelen S; Gibb D; Guiguet M; Judd A; Leport C; Dabis F; Pantazis N; Porter K; Raffi F; Thorne C; Torti C; Walker S; Warszawski J; Wintergerst U; Chene G; Lundgren J
    AIDS; 2008 Jul; 22(12):1463-73. PubMed ID: 18614870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries.
    Han WM; Law MG; Egger M; Wools-Kaloustian K; Moore R; McGowan C; Kumarasamy N; Desmonde S; Edmonds A; Davies MA; Yiannoutsos C; Althoff KN; Cortes CP; Mohamed TJ; Jaquet A; Anastos K; Euvrard J; Castelnuovo B; Salters K; Coelho LE; Ekouevi DK; Eley B; Diero L; Zaniewski E; Ford N; Sohn AH; Kariminia A;
    Lancet HIV; 2021 Dec; 8(12):e766-e775. PubMed ID: 34856180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respective roles of migration and social deprivation for virological non-suppression in HIV-infected adults on antiretroviral therapy in France.
    Raho-Moussa M; Guiguet M; Michaud C; Honoré P; Palacios C; Boué F; Azghay M; Kansau I; Chambrin V; Kandel T; Favier M; Miekoutima E; Sayre N; Pignon C; Shoai M; Bouchaud O; Abgrall S
    PLoS One; 2019; 14(3):e0213019. PubMed ID: 30845270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain.
    Monge S; Alejos B; Dronda F; Del Romero J; Iribarren JA; Pulido F; Rubio R; Miró JM; Gutierrez F; Del Amo J;
    HIV Med; 2013 May; 14(5):273-83. PubMed ID: 23171059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.